BioSpace News Archive

Ascentage Pharma announced a combination therapy strategic collaboration with Henlius, working together to conduct clinical trials of the combination therapy between APG-2575, a novel, orally administered Bcl-2 selective inhibitor developed by Ascentage Pharma, and HLX01, the first launched product by Henlius, for the treatment of chronic lymphocytic leukemia in the People’s Republic of China.

Amarin Corporation plc, a pharmaceutical company focused on improving cardiovascular health, announced that two independently conducted studies, two moderated poster sessions and three presentations based on research supported by Amarin will be presented at the American Heart Association’s 2019 Scientific Sessions, November 16-18, in Philadelphia, PA.

NiKang Therapeutics, an early stage biotech company focused on discovering and developing innovative small molecule oncology medicines to help patients with unmet medical needs, announced the appointment of Y. Peter Li, Ph.D., MBA, as Chief Executive Officer and Board Director.

Bill Gates Funds $10 Million Grant in Match Challenge to Fuel Research and Accelerate Alzheimer’s Treatment [04-November-2019] CHICAGO , Nov. 4, 2019 /PRNewswire/ -- Bill Gates is joining the Alzheimer’s Association Part the Cloud global research grant program led by visionary philanthropist Mikey Hoag . Gates’ award of $10 million will stimulate an additional

RedHill plans to launch Talicia®1in the U.S. in Q1/2020 for the treatment of H. pylori infection in adults, targeting more than two million patients estimated to be treated for H. pylori infection annually

The announcement by the AMA that the procedure for fluorescence imaging of bacteria will receive a Category lll CPT code is an extremely exciting milestone both for MolecuLight and for the growing body of clinical users of the i:X handheld fluorescence imaging device

Transaction creates the leading provider of HEOR, market access, medical affairs and healthcare communications services to pharmaceutical companies across US, Europe and Asia

MediPharm Labs Corp. a global leader in specialized, research-driven cannabis extraction, distillation and purification, is pleased to announce Robert Kwon will join MediPharm Labs as Chief Financial Officer, effective November 18, 2019.

Rockwell Medical, Inc. announced that the Company will release its 2019 third quarter financial results on Monday, November 11, 2019, after the close of the U.S. financial markets.

Prescription-strength CelleRx to gently clean skin and ease post-procedure discomfort is now available without a prescription at www.CelleRx.com